lapatinib has been researched along with cefamandole nafate in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (cefamandole nafate) | Trials (cefamandole nafate) | Recent Studies (post-2010) (cefamandole nafate) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 14 | 0 | 6 |
| Protein | Taxonomy | lapatinib (IC50) | cefamandole nafate (IC50) |
|---|---|---|---|
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | 0.1 | |
| M17 leucyl aminopeptidase | Plasmodium falciparum 3D7 | 12.08 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
1 other study(ies) available for lapatinib and cefamandole nafate
| Article | Year |
|---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |